Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9684167 | 0.91 | ALDH1A1 (0.31) | HTT | |
| SCHEMBL9683465 | 0.80 | CARM1 (0.33) | OPRM1SLC6A2SLC6A3 | |
| SCHEMBL9684632 | 0.78 | SLC6A2 (0.36) | OPRM1HTTSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL9684133 | 0.78 | CYP2D6 (0.38) | OPRM1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL9683338 | 0.78 | POLB (0.34) | — | |
| SCHEMBL9684243 | 0.77 | CHRM2 (0.37) | HTT | |
| SCHEMBL9684281 | 0.76 | OPRM1 (0.37) | OPRM1 | |
| SCHEMBL9682581 | 0.74 | HTT (0.35) | HTTSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL9684260 | 0.73 | DUT (0.33) | — | |
| SCHEMBL9682616 | 0.71 | KDM1A (0.46) | SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0475187-A1 | Naphthothiophenimines for treating neuronal disorders caused by ischemia | BRISTOL-MYERS SQUIBB COMPANY (US) | 1992-03-18 | — | — | EP | disclosed |
| US-5064831-A | N-methyl-d-aspartate receptor antagonist | BRISTOL-MYERS SQUIBB CO. (US) | 1991-11-12 | — | — | US | disclosed |